Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

Bacterium present in eyes with 'wet' age-related macular degeneration

November 08, 2005

BOSTON - Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD). However, it was not found in the eyes of more than 20 individuals without AMD, providing more evidence that this disease may be caused by inflammation. The study is described in the November issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

AMD is the leading cause of blindness in Americans over the age of 55. The majority of vision loss is due to neovascular AMD, the advanced form of the disease characterized by the formation of blood vessels in the macula, the center part of the eye's retina. These blood vessels often leak, thus giving neovascular AMD the name of "wet" AMD.

Researchers at the MEEI and Harvard Medical School (HMS) examined nine wet AMD membranes for the presence of C. pneumoniae and also determined whether this pathogen can change the function of eye cells in ways that can cause wet AMD. They found C. pneumoniae in the eyes of five out of the nine patients with wet AMD. They also tested tissue from more than 20 people who did not have AMD and did not find C. pneumoniae in any of these normal eye tissues.

"The paper showed that C. pneumoniae is capable of modifying the function of important cell types involved in regulating normal eye function," said lead author Murat Kalayoglu, MD, PhD. "We found that C. pneumoniae infection led to increased production of vascular endothelial growth factor (VEGF), the key protein involved in wet AMD. That C. pneumoniae infection of human eye cell types increases VEGF production is therefore significant and could explain in part why VEGF levels are increased in many people with wet AMD." Kalayoglu is an HMS research fellow in ophthalmology at MEEI.

Most of the new medications either marketed or being developed to treat wet AMD, such as Macugen (EyeTech Pharmaceuticals) and Lucentis (Genetech) block VEGF.

The study comes at a time of great interest in inflammatory mediators of AMD. Over the past seven months, a flurry of high-impact papers have shown, in aggregate, that nearly 50 percent of AMD can be explained by variations in a gene called Complement Factor H (CFH). This gene makes a protein that regulates the immune and inflammatory responses of the body.

"Our hypothesis is that C. pneumoniae may be the key link between CFH and AMD," Kalayoglu said. "That is, patients with CFH variations may be particularly susceptible to the damaging effects of chronic infection, and an infectious organism like C. pneumoniae may be particularly effective in accelerating inflammation and driving progression of AMD in these patients."

Kalayoglu and colleagues are currently collaborating with CFH researchers to study this hypothesis. "It may be possible to stop or reverse progression of AMD by identifying susceptible patients by diagnostic testing, and then treating these susceptible patients. Although C. pneumoniae is a bacterium that might respond to some antibiotics, much more work needs to be done before considering antibiotic therapy for AMD," he said.

"This is an important study suggesting that infection with C. pneumoniae may be a critical link between a genetic predisposition to AMD and actual progression to disease," said Gerald I. Byrne, Ph.D., professor and chairman of the Department of Molecular Sciences University of Tennessee Health Sciences Center. "This is yet another example of how an infection may unexpectedly contribute to a chronic disease. Certainly the association of C. pneumoniae with heart disease sets the stage for this pathogen's involvement in other chronic conditions. This work is, in some ways, reminiscent of studies done more than 15 years ago on infections and ulcers. Those studies were viewed with skepticism, but Drs. Marshal and Warren, the researchers who pioneered that work received the Nobel Prize this year."

The Graefe's paper builds on data from the same group that showed, for the first time, that an infectious agent is associated with AMD by epidemiological studies (Archives of Ophthalmology, April 2003).

Harvard Medical School

Related Macular Degeneration Current Events and Macular Degeneration News Articles

Macular Degeneration Current Events and Macular Degeneration News RSS

Nutrition's Potential to Save Sight
While 20/20 vision is a symbol of visual acuity, between now and the year 2020, more and more people will experience some extent of vision loss due to age-related macular degeneration (AMD) and other sight-robbing diseases.

Link between iron overload and macular degeneration under study
The most common - and under-diagnosed - genetic disease in humans just may be a cause of the worst form of macular degeneration, Medical College of Georgia researchers report.

Wining and dining your way to better eyesight
Current research suggests that resveratrol, a naturally occurring compound found in red wine, grapes, blueberries, peanuts, and other plants, inhibits pathogenic new blood vessel growth.

Ingredient in red wine may prevent some blinding diseases
Resveratrol - found in red wine, grapes, blueberries, peanuts and other plants - stops out-of-control blood vessel growth in the eye, according to vision researchers at Washington University School of Medicine in St. Louis.

Inexpensive drug to stop sight loss shown to be effective
An inexpensive, but unlicensed drug to help prevent severe sight loss in older people has been shown to be safe and effective, finds a study published on bmj.com today.

UCI researchers create retina from human embryonic stem cells
UC Irvine scientists have created an eight-layer, early stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells.

AMD risk on the rise for Asians; retinal vein 'bypass' may help many CRVO patients
The May issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes a surprising, first report on increasing rates of age-related macular degeneration (AMD) among Asians, and describes an innovative "bypass" laser surgery that may help many people with central retinal vein occlusion (CRVO) avoid serious vision loss.

US Latinos have high rates of developing vision loss and certain eye conditions
Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease, and cataracts than non-Hispanic whites, researchers found. These are the first estimates of visual impairment and eye disease development in Latinos, the largest and fastest growing minority population in the United States.

Better vision ahead for many diabetic retinopathy patients
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD).

Bionic Vision Australia puts bionic eye in sight
Bionic Vision Australia (BVA) today unveils their wide-view neurostimulator concept - a bionic eye that will be implanted into Australia's first recipient of the technology.

More Macular Degeneration Current Events and Macular Degeneration News Articles

	Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas G. Mogk (Author), Marja Mogk (Author) The acclaimed book on macular degeneration—now completely revised and updated with cutting edge research and the latest developments in the field. More than fifteen million Americans have age-related macular degeneration (AMD), and the disease will strike 200,000 more people this year. It is the most prevalent cause of vision loss in the western world. Dr. Lylas Mogk, the founding director of the Visual Rehabilitation and Research Center of the Henry Ford Health System, has a unique professional and personal understanding of AMD. A doctor and loving daughter of a parent with this frightening though manageable condition, Mogk here explains exactly what it is and how to limit its effect on your life. Reassuring and comprehensive—complete with illuminating first person stories of...
	Overcoming Macular Degeneration: A Guide to Seeing Beyond the Clouds by J.D. Solomon (Contributor) Each year, more than 400,000 Americans are diagnosed with macular degeneration, an age-related, progressive eye disease that immediately raises a fear of total blindness. The good news is: YOU ARE NOT GOING BLIND. However, you are dealing with a disease that causes serious visual impairment?an inconvenience the author, Dr. Yale Solomon, is personally familiar with because he has macular degeneration. Now this respected ophthalmologist offers a compassionate and understanding look at both the medical and human side of macular degeneration and ways to meet the challenge of its impact on everyday life. This newly updated edition includes a comprehensive appendix of associations, organizations and foundations, large-print publishers, audio and video resources, and a helpful list of suppliers...
	Macular Degeneration: A Complete Guide for Patients and Their Families by Michael A. Samuel (Author) For people who start losing their vision to macular degeneration, the prospect of impending blindness is frightening and terribly depressing. They often get contradictory advice about surgery, medical treatments, natural supplements, and lifestyle changes that might arrest or reverse the condition, and these conflicting recommendations only compound their anxiety. Finally, in Macular Degeneration: A Complete Guide for Patients and Their Families, patients and their loved ones can turn to one easy-to-understand and authoritative source for up-to-date information about macular degeneration. Written by renowned ophthalmologist Michael Samuel, M.D., a retinal specialist, this book casts the spotlight on macular degeneration and dispels the myths surrounding this...
	Macular Disease: Practical Strategies for Living with Vision Loss by Peggy R. Wolfe (Author) This invaluable guide to living well with vision loss is the perfect blend of abundant factual material and real-life experience. The book's positive, take-charge approach offers reassurance, hope, and hundreds of proven techniques, strategies, and tips for both the newly diagnosed and those at later stages of their disease. "My Story" vignettes in each chapter describe the author's fears, foibles, and triumphs in challenging situations. Readers will identify with the author's experiences and be encouraged by knowing she successfully traveled the same path. This oversize handbook has large, dark type and is printed on glare-resistant paper for ease in reading by people with low vision.
	The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts (Author) Age-related macular degeneration (AMD) is a progressive disease of the retina wherein the light-sensing cells in the central area of vision (the macula) stop working and eventually die. AMD is the leading cause of legal blindness in people over 50. From the moment of his own diagnosis, educator and musician Dan Roberts has made it his mission to provide the most up-to-date information about AMD, its effects and challenges, through his website at mdsupport.org. Receiving over 60,000 unique visitors monthly, MD Support is the go-to for all things AMD. Now, as a "patient-expert," Roberts applies his wealth of knowledge to the First Year series, providing crucial information for the newly diagnosed, including cutting edge therapies, and tips on how to navigate everyday tasks with diminishing...
	VisiVite iDefense Gold Macular Degeneration Eye Vitamin Formula by Vitamin Science Inc VisiVite i-Defense Gold Formula is the most powerful macular degeneration supplement available. It contains 15mg FloraGLO brand Lutein, Anti-Oxidants, Zinc and 4.75mg OPTISHARP brand Zeaxanthin to promote retinal health in patients who have macular degeneration.
	Conquering Macular Degeneration: The Latest Breakthroughs and Treatments by Edward L. Paul (Author) Macular degenertaion is the leading cause of blindness for those over the age of 65 and affects as many as 15 million North Americans. That number is projected to grow to an epidemic 30 million by 2010. "Getting old and going blind is not your only option! What most eye doctors are telling their patients is that there is no treatment for this disease... and that simply isn't true." These controversial words come from one of the nation's leading authorities on eye disease, Dr. Edward L. Paul, Jr. This ground breaking book discloses the latest breakthroughs and treatments for macular degeneration. Debunking the myths that surround this blinding disease, Dr. Paul discusses new research evolving in the field of nutrition as well as cutting edge therapies in electro medicine such as...
	Overcoming Macular Degeneration: A Guide to Seeing Beyond the Clouds by BookSurge Each year, more than 400,000 Americans are diagnosed with macular degeneration, an age-related, progressive eye disease that immediately raises a fear of total blindness. The good news is: YOU ARE NOT GOING BLIND. However, you are dealing with a disease that causes serious visual impairment—an inconvenience the author, Dr. Yale Solomon, is personally familiar with because he has macular degeneration. Now this respected ophthalmologist offers a compassionate and understanding look at both the medical and human side of macular degeneration and ways to meet the challenge of its impact on everyday life. This newly updated edition includes a comprehensive appendix of associations, organizations and foundations, large-print publishers, audio and video resources, and a helpful list of...
	Save Your Sight! : Natural Ways to Prevent and Reverse Macular Degeneration by Marc R. Rose (Author), Michael R. Rose (Author) Macular degeneration, an affliction of progressive vision loss, is the leading cause of blindness in the United States. This remarkable volume shows how diet, nutritional supplements, exercise and certain lifestyle choices can halt, reverse, or even prevent the onslaught of this devastating disease.
	Macular Degeneration: The Latest Scientific Discoveries and Treatments for Preserving Your Sight by Robert D'Amato M.D. Ph.D. (Author), Joan Snyder (Author), M.D., Ph.D. Robert D'Amato (Author) Dr. Robert D'Amato, MD, PhD of Harvard Medical School,and recent winner of the Lew Wasserman award for his pioneering eye research, has teamed up with ARMD sufferer and writer Joan Snyder,to produce Macular Degeneration: The Latest Scientific Discoveries and Treatments for Preserving Your Sight. Endorsed by the Macular Degeneration Foundation, this easy-to-read large type edition is the only book written for laymen that covers all of the latest scientific discoveries and promising research for age-related macular degeneration. Learn more about Visudyne (photodynamic therapy), laser therapy, nutrition and drug therapy. Dr. D'Amato covers alternative or complimentaty therapies such as acupuncture, meditation, microcurrent stimulation and more. Promising medical research initiatives...